Effectiveness of glucose-lowering medications on cardiovascular outcomes in patients with type 2 diabetes at moderate cardiovascular risk.
Publication Title
Nat Cardiovasc Res
Document Type
Article
Publication Date
4-1-2024
Keywords
washington; spokane; pmrc
Abstract
Cardiovascular disease (CVD) is the leading cause of death among people with type 2 diabetes1-5, most of whom are at moderate CVD risk6, yet there is limited evidence on the preferred choice of glucose-lowering medication for CVD risk reduction in this population. Here, we report the results of a retrospective cohort study where data for US adults with type 2 diabetes and moderate risk for CVD are used to compare the risks of experiencing a major adverse cardiovascular event with initiation of glucagon-like peptide-1 receptor agonists (GLP-1RA; n = 44,188), sodium-glucose cotransporter 2 inhibitors (SGLT2i; n = 47,094), dipeptidyl peptidase-4 inhibitors (DPP4i; n = 84,315) and sulfonylureas (n = 210,679). Compared to DPP4i, GLP-1RA (hazard ratio (HR) 0.87; 95% confidence interval (CI) 0.82-0.93) and SGLT2i (HR 0.85; 95% CI 0.81-0.90) were associated with a lower risk of a major adverse cardiovascular event, whereas sulfonylureas were associated with a higher risk (HR 1.19; 95% CI 1.16-1.22). Thus, GLP-1RA and SGLT2i may be the preferred glucose-lowering agents for cardiovascular risk reduction in patients at moderate baseline risk for CVD. ClinicalTrials.gov registration: NCT05214573.
Clinical Institute
Cardiovascular (Heart)
Clinical Institute
Kidney & Diabetes
Specialty
Cardiology
Specialty
Nephrology
Specialty
Pharmacy
Recommended Citation
McCoy, Rozalina G; Herrin, Jeph; Swarna, Kavya Sindhu; Deng, Yihong; Kent, David M; Ross, Joseph S; Umpierrez, Guillermo E; Galindo, Rodolfo J; Crown, William H; Borah, Bijan J; Montori, Victor M; Brito, Juan P; Neumiller, Joshua J; Mickelson, Mindy M; and Polley, Eric C, "Effectiveness of glucose-lowering medications on cardiovascular outcomes in patients with type 2 diabetes at moderate cardiovascular risk." (2024). Articles, Abstracts, and Reports. 9014.
https://digitalcommons.providence.org/publications/9014